Left Menu
Development News Edition

Fabindia appoints Aditya Ghosh to board of directors

Fabindia, which operates a chain of stores selling a range of artisans products, on Wednesday said former Indigo airlines president Aditya Ghosh has been appointed as a member of its board of directors.

PTI | New Delhi | Updated: 01-07-2020 15:05 IST | Created: 01-07-2020 15:05 IST
Fabindia appoints Aditya Ghosh to board of directors

Fabindia, which operates a chain of stores selling a range of artisans products, on Wednesday said former Indigo airlines president Aditya Ghosh has been appointed as a member of its board of directors. Ghosh will be guiding the management teams with strategy and new initiatives, the company said in a statement.

"Fabindia believes that the post-Covid period will bring about transformational change in consumer behaviour and brands with purpose, sustainability initiatives and earth-friendly commerce will become increasingly important...As we evolve towards a new normal, we are excited to have Aditya on board helping with strategy and growth," the company said. Ghosh is a seasoned professional with over 22 years of experience and has had multiple roles including leading IndiGo and also OYO Hotels & Homes.

On his joining the board of Fabindia, Ghosh said, "I am looking forward to engaging with a sense of purpose where we continue to build on the tremendous trust that the Fabindia family of brands enjoy and create a socially conscious business that makes a deep positive impact towards a healthier and more equal planet." Fabindia operates 327 stores across 118 cities in India and 14 international stores selling a wide range of products produced by artisans living largely in rural areas..


TRENDING

OPINION / BLOG / INTERVIEW

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

COVID-19: Weighing up the benefits and limitations of edtech platforms

Edtech companies shouldnt focus on merely pushing contents, but to provide an interactive, effective teaching and learning environment. ...

Shipping industry's COVID-19 resilience test could boost digitalization

The push towards digitalization in shipping industry was already happening and has been further accelerated by the pandemic as current practices are not tenable under present circumstances and would definitely not be in the future....

Health is pure science but why objectivity eludes WHO

We certainly need a global body to coordinate responses against health emergencies. However, this sheer need of humanity on this planet should not be milked by the World Organization WHO to overshadow constructive criticism and call for ref...

Videos

Latest News

India's trade deficit with China reduces to USD 48.66 bn in FY20

Indias trade deficit with China fell to USD 48.66 billion in 2019-20 on account of decline in imports from the neighbouring country, according to government data. Exports to China in the last financial year stood at USD 16.6 billion, while ...

Bankers pledge continuing support to MSMEs during post-COVID era

Acknowledging the liquidity crisis being faced by the MSMEs, leading bankers of the country on Thursday said they will continue to lend their support to these units even during the post-COVID era. There is a need for the bankers to provide ...

Ramagya School Noida Keeps up the Momentum of Studies through Regular Virtual Classes

Studies go on unhampered at Ramagya School Noida via virtual classes and the students adapt themselves to virtual mode of education during the COVID-19 induced lockdown Delhi NCR, India NewsVoirRamagya School, Noida, one of the pioneering s...

Pharma major Mylan gets go-ahead to make remdesivir for 'restricted emergency use'

After Hetero and Cipla, another pharmaceutical major Mylan was given permission by Indias drug regulator on Thursday to manufacture and market the anti-viral drug remdesivir for restricted emergency use on hospitalised COVID-19 pa...

Give Feedback